| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |